JP2008504304A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008504304A5 JP2008504304A5 JP2007518382A JP2007518382A JP2008504304A5 JP 2008504304 A5 JP2008504304 A5 JP 2008504304A5 JP 2007518382 A JP2007518382 A JP 2007518382A JP 2007518382 A JP2007518382 A JP 2007518382A JP 2008504304 A5 JP2008504304 A5 JP 2008504304A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- compound
- heteroalkyl
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*(*)CC(CC1)CC2=C1N=C(C(*)N(N*)I*)N(*)C2=O Chemical compound C*(*)CC(CC1)CC2=C1N=C(C(*)N(N*)I*)N(*)C2=O 0.000 description 1
- FKQYECMKLWYTCQ-UHFFFAOYSA-N CC(Cc1ccc(C(F)(F)F)c(F)c1)=O Chemical compound CC(Cc1ccc(C(F)(F)F)c(F)c1)=O FKQYECMKLWYTCQ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58382304P | 2004-06-28 | 2004-06-28 | |
| PCT/US2005/023275 WO2006004925A1 (en) | 2004-06-28 | 2005-06-28 | Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008504304A JP2008504304A (ja) | 2008-02-14 |
| JP2008504304A5 true JP2008504304A5 (enExample) | 2008-08-14 |
Family
ID=34982539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007518382A Pending JP2008504304A (ja) | 2004-06-28 | 2005-06-28 | テトラヒドロキナゾリン−４（３ｈ）−オン関連、及びテトラヒドロピリド［２，３−ｄ］ピリミジン−４（３ｈ）−オン関連化合物、組成物、及びそれらの使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7375102B2 (enExample) |
| EP (1) | EP1765818A1 (enExample) |
| JP (1) | JP2008504304A (enExample) |
| AU (1) | AU2005260630A1 (enExample) |
| CA (1) | CA2572084A1 (enExample) |
| MX (1) | MX2007000044A (enExample) |
| WO (1) | WO2006004925A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858615B2 (en) | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
| US7939538B2 (en) * | 2004-06-28 | 2011-05-10 | Amgen Inc. | Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| TW200714610A (en) * | 2005-02-16 | 2007-04-16 | Univ Maryland | CXCR3 is a gliadin receptor |
| EP1889622A4 (en) * | 2005-05-31 | 2009-12-23 | Ono Pharmaceutical Co | SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF |
| WO2007002701A2 (en) * | 2005-06-27 | 2007-01-04 | Amgen Inc. | Anti-inflammatory aryl nitrile compounds |
| US20110034487A1 (en) * | 2008-01-22 | 2011-02-10 | Amgen Inc. | Cxcr3 antagonists |
| WO2010047674A1 (en) | 2008-10-20 | 2010-04-29 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Low molecular weight thyroid stimulating hormone receptor (tshr) agonists |
| AU2011237421B2 (en) | 2010-04-08 | 2016-10-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inverse agonists and neutral antagonists for the TSH receptor |
| WO2013003444A1 (en) | 2011-06-27 | 2013-01-03 | Michael Ross Johnson | A chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity |
| AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
| CN103781776A (zh) | 2011-07-13 | 2014-05-07 | 诺华股份有限公司 | 用作端锚聚合酶抑制剂的新的2-哌啶-1-基-乙酰胺化合物 |
| CN103814032A (zh) | 2011-07-13 | 2014-05-21 | 诺华股份有限公司 | 用作端锚聚合酶抑制剂的4-氧代-3,5,7,8-四氢-4H-吡喃并[4,3-d]嘧啶基化合物 |
| EA201490272A1 (ru) | 2011-07-13 | 2014-05-30 | Новартис Аг | Новые 4-пиперидинильные соединения для применения в качестве ингибиторов танкиразы |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| AU2013267504B2 (en) | 2012-05-29 | 2017-11-02 | Parion Sciences, Inc. | Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
| BR112015014178A2 (pt) | 2012-12-17 | 2017-07-11 | Parion Sciences Inc | compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida |
| CA2896686A1 (en) | 2012-12-17 | 2014-06-26 | Parion Sciences, Inc. | 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds |
| SG11201504799QA (en) | 2012-12-17 | 2015-07-30 | Parion Sciences Inc | Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration |
| EA201690713A1 (ru) | 2013-10-04 | 2016-08-31 | Инфинити Фармасьютикалз, Инк. | Гетероциклические соединения и их применения |
| WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
| EP4066834A1 (en) | 2014-03-19 | 2022-10-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
| US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
| NZ740616A (en) | 2015-09-14 | 2023-05-26 | Infinity Pharmaceuticals Inc | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
| WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
| US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| TWI816696B (zh) * | 2017-09-14 | 2023-10-01 | 日商住友金屬礦山股份有限公司 | 近紅外線吸收纖維及使用其之纖維製品 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0481614A1 (en) | 1990-10-01 | 1992-04-22 | Merck & Co. Inc. | Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists |
| US5256667A (en) * | 1991-09-25 | 1993-10-26 | Merck & Co., Inc. | Quinazolinones and pyridopyrimidinones |
| US5202322A (en) * | 1991-09-25 | 1993-04-13 | Merck & Co., Inc. | Quinazolinone and pyridopyrimidine a-II antagonists |
| US5756502A (en) * | 1994-08-08 | 1998-05-26 | Warner-Lambert Company | Quinazolinone derivatives as cholyecystokinin (CCK) ligands |
| US5719144A (en) * | 1995-02-22 | 1998-02-17 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| WO1996028444A1 (en) * | 1995-03-15 | 1996-09-19 | Pfizer Inc. | 5,10-DIHYDROPYRIMIDO[4,5-b]QUINOLIN-4(1H)-ONE TYROSINE KINASE INHIBITORS |
| US6140064A (en) * | 1996-09-10 | 2000-10-31 | Theodor-Kocher Institute | Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3 |
| FR2778662B1 (fr) | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| ATE342257T1 (de) * | 1999-08-27 | 2006-11-15 | Chemocentryx Inc | Heterozyclische verbindungen und verfahren zur modulierung von cxcr3 funktion |
| WO2001019800A2 (en) | 1999-09-16 | 2001-03-22 | Curis, Inc. | Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| IL149164A0 (en) | 1999-10-27 | 2002-11-10 | Cytokinetics Inc | Methods and compositions utilizing quinazolinones |
| GB2359551A (en) | 2000-02-23 | 2001-08-29 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
| EA007538B1 (ru) * | 2000-12-11 | 2006-10-27 | Туларик Инк. | Антагонисты cxcr3 |
| US6794379B2 (en) * | 2001-06-06 | 2004-09-21 | Tularik Inc. | CXCR3 antagonists |
| ATE507210T1 (de) | 2002-03-07 | 2011-05-15 | X Ceptor Therapeutics Inc | Chinazolinon modulatoren von nukleinrezeptoren |
| US7166595B2 (en) * | 2002-05-09 | 2007-01-23 | Cytokinetics, Inc. | Compounds, methods and compositions |
| US20040242498A1 (en) | 2003-02-27 | 2004-12-02 | Collins Tassie L. | CXCR3 antagonists |
| AU2004229404B2 (en) | 2003-04-11 | 2008-01-10 | Taigen Biotechnology | Aminoquinoline compounds |
-
2005
- 2005-06-27 US US11/168,006 patent/US7375102B2/en not_active Expired - Fee Related
- 2005-06-28 MX MX2007000044A patent/MX2007000044A/es active IP Right Grant
- 2005-06-28 AU AU2005260630A patent/AU2005260630A1/en not_active Abandoned
- 2005-06-28 JP JP2007518382A patent/JP2008504304A/ja active Pending
- 2005-06-28 EP EP05768335A patent/EP1765818A1/en not_active Withdrawn
- 2005-06-28 WO PCT/US2005/023275 patent/WO2006004925A1/en not_active Ceased
- 2005-06-28 CA CA002572084A patent/CA2572084A1/en not_active Abandoned